Biocept, Inc., Pipeline Review, Upcoming Catalysts and Milestones
NEW YORK, NY / ACCESSWIRE / January 30, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Biocept, Inc. (BIOC), a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with information for treating and monitoring patients diagnosed with cancer.
Biocept is an emerging player in the liquid biopsy space and the key for Biocept is to continue to raise awareness about its technology platform. Furthermore, 2019 is expected to be a remarkable year for biotech space and oncology/cancer segment will likely continue to dominate the industry.
BIOC upcoming catalysts and milestones are discussed here READ MORE
Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/biocept/
BIOC's liquid biopsy assays can be particularly useful when there is insufficient sample material to perform a tissue biopsy or when a tissue biopsy has proven inadequate for identifying actionable biomarkers required to support the use of targeted drug therapy. The overall Liquid Biopsy Market Estimated at $17+ Billion and has extreme Potential to improve cancer patient outcomes.
Review the company pipeline and potential catalyst dates here READ MORE
Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/biocept/
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source
